| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.783 | 0.003 | 0.783 | Butyrylcholinesterase inhibitor | |||
| 0.711 | 0.004 | 0.711 | Cholinergic | |||
| 0.66 | 0.004 | 0.66 | Acetylcholinesterase inhibitor | |||
| 0.633 | 0.009 | 0.65 | Immunosuppressant | 0.65 0.008 CID_654 | CID_654 | |
| 0.45 | 0.037 | 0.527 | Immunostimulant | 0.527 0.026 CID_654 | CID_654 | |
| 0.285 | 0.035 | 0.564 | RNA-directed DNA polymerase inhibitor | 0.564 0.007 CID_654 0.341 0.025 CID_23017 | CID_654 | |
| 0.252 | 0.011 | 0.412 | Mannose-6-phosphate isomerase inhibitor | 0.412 0.003 CID_654 0.196 0.033 CID_23017 | CID_654 | |
| 0.246 | 0.013 | 0.532 | UDP-glucose 4-epimerase inhibitor | 0.532 0.002 CID_654 0.196 0.019 CID_23017 | CID_654 | |
| 0.209 | 0.005 | 0.209 | Cannabinoid CB1 receptor antagonist | 0.064 0.04 CID_23017 | ||
| 0.249 | 0.051 | 0.744 | Anesthetic general | 0.744 0.003 CID_654 | CID_654 | |
| 0.199 | 0.008 | 0.199 | Cannabinoid receptor antagonist | |||
| 0.192 | 0.013 | 0.64 | Sphingosine 1-phosphate receptor 2 agonist | 0.64 0.002 CID_654 | CID_654 | |
| 0.174 | 0.004 | 0.174 | Oleamide hydrolase inhibitor | |||
| 0.18 | 0.015 | 0.313 | Sphingosine 1-phosphate receptor 2 antagonist | 0.313 0.003 CID_654 0.131 0.071 CID_23017 | CID_654 | |
| 0.186 | 0.04 | 0.674 | Bone formation stimulant | 0.674 0.003 CID_654 | CID_654 | |
| 0.147 | 0.009 | 0.274 | Sphingosine 1-phosphate receptor 4 agonist | 0.274 0.003 CID_654 0.098 0.026 CID_23017 | CID_654 | |
| 0.139 | 0.005 | 0.139 | Angiotensin-converting enzyme inhibitor | 0.056 0.036 CID_654 | ||
| 0.141 | 0.02 | 0.525 | NADH dehydrogenase inhibitor | 0.525 0.003 CID_654 0.135 0.022 CID_23017 | CID_654 | |
| 0.165 | 0.045 | 0.165 | Cholinergic antagonist | |||
| 0.158 | 0.048 | 0.283 | Sphingosine 1-phosphate receptor 5 antagonist | 0.283 0.003 CID_654 0.126 0.11 CID_23017 | CID_654 | |
| 0.111 | 0.005 | 0.496 | Sphingosine 1-phosphate receptor 3 agonist | 0.496 0.002 CID_654 | CID_654 | |
| 0.142 | 0.041 | 0.377 | Sphingosine 1-phosphate receptor 4 antagonist | 0.377 0.003 CID_654 0.115 0.082 CID_23017 | CID_654 | |
| 0.15 | 0.049 | 0.563 | DNA polymerase I inhibitor | 0.563 0.003 CID_654 | CID_654 | |
| 0.209 | 0.11 | 0.554 | DNA synthesis inhibitor | 0.554 0.01 CID_654 0.179 0.155 CID_23017 | CID_654 | |
| 0.126 | 0.029 | 0.627 | Triose-phosphate isomerase inhibitor | 0.627 0.002 CID_654 0.107 0.042 CID_23017 | CID_654 | |
| 0.243 | 0.155 | 0.505 | Calcium channel activator | 0.505 0.005 CID_654 0.285 0.107 CID_23017 | CID_654 | |
| 0.106 | 0.019 | 0.437 | Carbamoyl phosphate synthetase inhibitor | 0.437 0.003 CID_654 0.118 0.016 CID_23017 | CID_654 | |
| 0.103 | 0.016 | 0.301 | Acyl-CoA dehydrogenase inhibitor | 0.301 0.001 CID_654 0.051 0.041 CID_23017 | CID_654 | |
| 0.228 | 0.142 | 0.348 | Cholesterol antagonist | 0.348 0.065 CID_654 0.225 0.144 CID_23017 | CID_654 | |
| 0.099 | 0.015 | 0.099 | Androgen agonist | 0.07 0.03 CID_654 0.077 0.026 CID_23017 | ||
| 0.205 | 0.127 | 0.487 | Transcription factor STAT3 inhibitor | 0.487 0.008 CID_654 | CID_654 | |
| 0.157 | 0.08 | 0.246 | Arachidonic acid antagonist | 0.246 0.006 CID_654 0.136 0.105 CID_23017 | CID_654 | |
| 0.12 | 0.043 | 0.44 | Adenylate kinase inhibitor | 0.44 0.002 CID_654 0.102 0.064 CID_23017 | CID_654 | |
| 0.083 | 0.012 | 0.516 | Sphingosine 1-phosphate receptor 5 agonist | 0.516 0.003 CID_654 | CID_654 | |
| 0.088 | 0.017 | 0.385 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.385 0.002 CID_654 0.053 0.043 CID_23017 | CID_654 | |
| 0.113 | 0.043 | 0.436 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.436 0.003 CID_654 0.204 0.015 CID_23017 | CID_654 | |
| 0.087 | 0.018 | 0.381 | Glutamate (mGluR6) antagonist | 0.381 0.002 CID_654 0.071 0.037 CID_23017 | CID_654 | |
| 0.158 | 0.09 | 0.59 | Phospholipase C inhibitor | 0.59 0.004 CID_654 | CID_654 | |
| 0.072 | 0.009 | 0.073 | Cholesterol esterase inhibitor | 0.073 0.009 CID_654 | CID_654 | |
| 0.091 | 0.029 | 0.202 | Sphingosine 1-phosphate receptor antagonist | 0.202 0.004 CID_654 | CID_654 | |
| 0.111 | 0.053 | 0.389 | Toll-Like receptor 4 antagonist | 0.389 0.003 CID_654 | CID_654 | |
| 0.157 | 0.1 | 0.241 | Succinate dehydrogenase inhibitor | 0.222 0.034 CID_654 0.241 0.026 CID_23017 | CID_23017 | |
| 0.07 | 0.017 | 0.133 | Nicotinic receptor alpha4 subunit antagonist | 0.133 0.005 CID_23017 | CID_23017 | |
| 0.061 | 0.007 | 0.318 | Purinergic P2X agonist | 0.318 0.001 CID_654 | CID_654 | |
| 0.141 | 0.09 | 0.372 | Hexokinase inhibitor | 0.372 0.005 CID_654 0.127 0.108 CID_23017 | CID_654 | |
| 0.059 | 0.008 | 0.21 | Purinergic P2Y2 antagonist | 0.21 0.001 CID_654 | CID_654 | |
| 0.048 | 0.005 | 0.188 | Growth factor receptor-bound protein 2 antagonist | 0.188 0.002 CID_654 | CID_654 | |
| 0.069 | 0.033 | 0.397 | Biliverdin reductase inhibitor | 0.397 0.002 CID_654 0.078 0.027 CID_23017 | CID_654 | |
| 0.057 | 0.021 | 0.23 | Glucose-6-phosphate isomerase inhibitor | 0.23 0.001 CID_654 0.045 0.039 CID_23017 | CID_654 | |
| 0.082 | 0.049 | 0.265 | Carbonic anhydrase XIII inhibitor | 0.265 0.008 CID_654 | CID_654 | |
| 0.085 | 0.053 | 0.209 | Glutathione S-transferase inhibitor | 0.209 0.005 CID_654 | CID_654 | |
| 0.248 | 0.217 | 0.549 | Apoptosis agonist | 0.549 0.06 CID_654 | CID_654 | |
| 0.074 | 0.045 | 0.415 | Phosphofructokinase-1 inhibitor | 0.415 0.003 CID_654 | CID_654 | |
| 0.062 | 0.035 | 0.21 | Sphingosine 1-phosphate receptor 3 antagonist | 0.21 0.003 CID_654 | CID_654 | |
| 0.128 | 0.104 | 0.4 | Phospholipase A2 inhibitor | 0.4 0.005 CID_654 | CID_654 | |
| 0.086 | 0.065 | 0.437 | Aminoacyl-tRNA synthetase inhibitor | 0.437 0.004 CID_654 | CID_654 | |
| 0.04 | 0.02 | 0.147 | Phosphoglycerate kinase inhibitor | 0.147 0.004 CID_654 | CID_654 | |
| 0.212 | 0.193 | 0.497 | GABA C receptor rho-3 antagonist | 0.401 0.061 CID_654 0.497 0.027 CID_23017 | CID_23017 | |
| 0.182 | 0.164 | 0.513 | Transcription factor STAT inhibitor | 0.513 0.007 CID_654 | CID_654 | |
| 0.03 | 0.012 | 0.267 | Toll-Like receptor 4 agonist | 0.267 0.001 CID_654 | CID_654 | |
| 0.043 | 0.026 | 0.094 | Thymidine kinase inhibitor | 0.094 0.007 CID_654 0.059 0.014 CID_23017 | CID_654 | |
| 0.017 | 0.003 | 0.107 | Mannitol 2-dehydrogenase inhibitor | 0.107 0 CID_654 | CID_654 | |
| 0.044 | 0.031 | 0.142 | Sphingosine 1-phosphate receptor agonist | 0.142 0.004 CID_654 | CID_654 | |
| 0.099 | 0.088 | 0.332 | Cholesterol synthesis inhibitor | 0.332 0.008 CID_654 | CID_654 | |
| 0.13 | 0.122 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.163 0.02 CID_654 0.155 0.032 CID_23017 | CID_654 | |
| 0.016 | 0.01 | 0.155 | Purinergic receptor agonist | 0.155 0.001 CID_654 | CID_654 | |
| 0.016 | 0.01 | 0.155 | Purinergic P2 agonist | 0.155 0.001 CID_654 | CID_654 | |
| 0.017 | 0.01 | 0.201 | Purinergic P2Y1 antagonist | 0.201 0.002 CID_654 | CID_654 | |
| 0.113 | 0.107 | 0.203 | Vanilloid 1 agonist | 0.203 0.011 CID_654 | CID_654 | |
| 0.041 | 0.036 | 0.148 | Glutamate (mGluR group III) antagonist | 0.148 0.004 CID_654 0.051 0.02 CID_23017 | CID_654 | |
| 0.038 | 0.035 | 0.128 | Sphingosine 1-phosphate receptor 1 agonist | 0.128 0.004 CID_654 | CID_654 | |
| 0.012 | 0.01 | 0.136 | Purinergic P2Y agonist | 0.136 0.001 CID_654 | CID_654 | |
| 0.064 | 0.066 | 0.435 | Glutamate dehydrogenase inhibitor | 0.435 0.004 CID_654 0.071 0.055 CID_23017 | CID_654 | |
| 0.054 | 0.055 | 0.185 | Purinergic P2X1 antagonist | 0.185 0.004 CID_654 | CID_654 | |
| 0.017 | 0.018 | 0.035 | Methylmalonyl-CoA mutase inhibitor | 0.035 0.002 CID_654 | CID_654 | |
| 0.082 | 0.085 | 0.197 | Glutamate release inhibitor | 0.197 0.005 CID_23017 | CID_23017 | |
| 0.021 | 0.026 | 0.086 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.086 0.004 CID_654 0.031 0.017 CID_23017 | CID_654 | |
| 0.177 | 0.182 | 0.316 | Tyrosine 3 hydroxylase inhibitor | 0.263 0.057 CID_654 0.316 0.026 CID_23017 | CID_23017 | |
| 0.084 | 0.089 | 0.173 | Anabolic | 0.173 0.009 CID_654 | CID_654 | |
| 0.002 | 0.008 | 0.019 | Purinergic P2Y4 agonist | 0.019 0.001 CID_654 | CID_654 | |
| 0.043 | 0.049 | 0.173 | Lysophosphatidic acid 3 receptor antagonist | 0.173 0.002 CID_654 | CID_654 | |
| 0.08 | 0.087 | 0.292 | Sphingomyelinase inhibitor | 0.292 0.004 CID_654 | CID_654 | |
| 0.096 | 0.105 | 0.576 | Aldehyde dehydrogenase inhibitor | 0.576 0.004 CID_654 | CID_654 | |
| 0.008 | 0.02 | 0.109 | Lysophosphatidic acid receptor 3 agonist | 0.109 0.001 CID_654 | CID_654 | |
| 0.036 | 0.049 | 0.11 | Fructose-1,6-bisphosphatase inhibitor | 0.11 0.004 CID_654 | CID_654 | |
| 0.011 | 0.025 | 0.052 | Purinergic P2Y1 agonist | 0.052 0.002 CID_654 | CID_654 | |
| 0.019 | 0.035 | 0.105 | Lysophosphatidic acid receptor 1 agonist | 0.105 0.002 CID_654 | CID_654 | |
| 0.099 | 0.118 | 0.265 | Alkaline phosphatase inhibitor | 0.265 0.017 CID_654 | CID_654 | |
| 0.032 | 0.052 | 0.09 | Vanilloid 3 antagonist | 0.09 0.003 CID_654 | CID_654 | |
| 0.023 | 0.044 | 0.245 | Fumarate hydratase inhibitor | 0.245 0.003 CID_654 0.03 0.029 CID_23017 | CID_654 | |
| 0.073 | 0.094 | 0.14 | D-Ala-D-Ala ligase inhibitor | 0.14 0.007 CID_654 0.094 0.038 CID_23017 | CID_654 | |
| 0.02 | 0.043 | 0.051 | Thymidine phosphorylase inhibitor | 0.038 0.007 CID_654 0.051 0.005 CID_23017 | CID_23017 | |
| 0.011 | 0.034 | 0.153 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.153 0.002 CID_654 | CID_654 | |
| 0.074 | 0.098 | 0.346 | DNA directed RNA polymerase inhibitor | 0.346 0.005 CID_654 0.167 0.019 CID_23017 | CID_654 | |
| 0.007 | 0.032 | 0.019 | Purine nucleoside phosphorylase inhibitor | 0.019 0.004 CID_654 | CID_654 | |
| 0.006 | 0.032 | 0.015 | Purinergic P2Y2 agonist | 0.015 0.003 CID_654 | CID_654 | |
| 0 | 0.027 | 0.003 | Purinergic P2Y6 agonist | 0.003 0.002 CID_654 | CID_654 | |
| 0.033 | 0.062 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.065 0.005 CID_23017 | CID_23017 | |
| 0.029 | 0.058 | 0.119 | Glutamate (mGluR8) agonist | 0.119 0.002 CID_654 | CID_654 | |
| 0.04 | 0.07 | 0.104 | Antiviral (Hepatitis D) | 0.104 0.004 CID_654 | CID_654 | |
| 0.02 | 0.052 | 0.317 | Lysophosphatidic acid 2 receptor antagonist | 0.317 0.002 CID_654 | CID_654 | |
| 0.087 | 0.123 | 0.362 | Alpha-N-acetylglucosaminidase inhibitor | 0.362 0.011 CID_654 0.23 0.027 CID_23017 | CID_654 | |
| 0.029 | 0.069 | 0.125 | Geranyltranstransferase inhibitor | 0.125 0.003 CID_654 | CID_654 | |
| 0.046 | 0.094 | 0.6 | Porphobilinogen synthase inhibitor | 0.6 0.003 CID_654 | CID_654 | |
| 0.08 | 0.129 | 0.204 | DOPA decarboxylase inhibitor | 0.204 0.006 CID_654 0.098 0.079 CID_23017 | CID_654 | |
| 0.027 | 0.077 | 0.252 | Ornithine carbamoyltransferase inhibitor | 0.252 0.005 CID_654 | CID_654 | |
| 0.004 | 0.057 | 0.044 | Glutamate (mGluR6) agonist | 0.044 0.002 CID_654 | CID_654 | |
| 0.034 | 0.089 | 0.249 | Purinergic P2X2 antagonist | 0.249 0.003 CID_654 | CID_654 | |
| 0.011 | 0.067 | 0.077 | Uridine phosphorylase inhibitor | 0.077 0.004 CID_654 | CID_654 | |
| 0.023 | 0.079 | 0.088 | Phosphorylase inhibitor | 0.088 0.015 CID_654 0.065 0.022 CID_23017 | CID_654 | |
| 0.011 | 0.07 | 0.048 | Geranylgeranyltransferase inhibitor | 0.048 0.005 CID_654 | CID_654 | |
| 0.015 | 0.075 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 CID_654 | CID_654 | |
| 0.051 | 0.112 | 0.094 | Exportin-1 inhibitor | 0.094 0.012 CID_23017 | CID_23017 | |
| 0.031 | 0.091 | 0.296 | Argininosuccinate synthase inhibitor | 0.296 0.004 CID_654 | CID_654 | |
| 0.029 | 0.09 | 0.057 | CC chemokine 4 receptor antagonist | 0.057 0.019 CID_23017 | CID_23017 | |
| 0.036 | 0.098 | 0.369 | Autotaxin inhibitor | 0.369 0.004 CID_654 | CID_654 | |
| 0.007 | 0.071 | 0.02 | Nicotinic alpha4 receptor agonist | 0.02 0.007 CID_23017 | CID_23017 | |
| 0.223 | 0.287 | 0.571 | Caspase 9 stimulant | 0.571 0.041 CID_654 0.321 0.172 CID_23017 | CID_654 | |
| 0.076 | 0.142 | 0.293 | Folate antagonist | 0.293 0.004 CID_654 | CID_654 | |
| 0.071 | 0.14 | 0.303 | GABA C receptor antagonist | 0.303 0.004 CID_654 0.134 0.04 CID_23017 | CID_654 | |
| 0.039 | 0.109 | 0.15 | Sphingosine 1-phosphate receptor 1 antagonist | 0.15 0.004 CID_654 | CID_654 | |
| 0.102 | 0.172 | 0.454 | Pyruvate kinase inhibitor | 0.454 0.013 CID_654 | CID_654 | |
| 0.011 | 0.081 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.041 0.007 CID_23017 | CID_23017 | |
| 0.073 | 0.144 | 0.212 | Glutamate (mGluR7) agonist | 0.212 0.004 CID_654 | CID_654 | |
| 0.08 | 0.15 | 0.371 | Toll-Like receptor 2 antagonist | 0.371 0.003 CID_654 | CID_654 | |
| 0.018 | 0.09 | 0.211 | Purinergic P2Y antagonist | 0.211 0.004 CID_654 | CID_654 | |
| 0.012 | 0.087 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.049 0.005 CID_23017 | CID_23017 | |
| 0.011 | 0.086 | 0.049 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.049 0.004 CID_654 | CID_654 | |
| 0.04 | 0.123 | 0.093 | Adenine nucleotide translocase inhibitor | 0.093 0.005 CID_654 | CID_654 | |
| 0.016 | 0.099 | 0.05 | Carnitine palmitoyltransferase 1 inhibitor | 0.05 0.008 CID_654 | CID_654 | |
| 0.036 | 0.12 | 0.357 | Histidine decarboxylase inhibitor | 0.357 0.005 CID_654 | CID_654 | |
| 0.039 | 0.123 | 0.07 | Pregnane X receptor antagonist | 0.07 0.014 CID_23017 | CID_23017 | |
| 0.007 | 0.092 | 0.031 | Adenosine kinase inhibitor | 0.031 0.009 CID_654 | CID_654 | |
| 0.144 | 0.231 | 0.256 | Nitric-oxide synthase stimulant | 0.2 0.089 CID_654 0.256 0.029 CID_23017 | CID_23017 | |
| 0.019 | 0.107 | 0.174 | Antimetabolite | 0.174 0.011 CID_654 | CID_654 | |
| 0.046 | 0.134 | 0.183 | Potassium channel (Ca-activated) activator | 0.183 0.018 CID_654 0.079 0.076 CID_23017 | CID_654 | |
| 0.014 | 0.103 | 0.05 | Carnitine palmitoyltransferase inhibitor | 0.05 0.008 CID_654 | CID_654 | |
| 0.027 | 0.12 | 0.066 | Purinergic P2X4 antagonist | 0.066 0.011 CID_654 0.049 0.025 CID_23017 | CID_654 | |
| 0.105 | 0.201 | 0.3 | Non-steroidal antiinflammatory agent | 0.3 0.028 CID_654 | CID_654 | |
| 0.019 | 0.119 | 0.054 | Glutamate (mGluR4) agonist | 0.054 0.01 CID_654 | CID_654 | |
| 0.096 | 0.195 | 0.24 | Adenylate cyclase stimulant | 0.24 0.005 CID_654 0.127 0.108 CID_23017 | CID_654 | |
| 0.009 | 0.112 | 0.059 | Lysophosphatidic acid 1 receptor antagonist | 0.059 0.003 CID_654 | CID_654 | |
| 0.028 | 0.132 | 0.279 | Purinergic P2 antagonist | 0.279 0.005 CID_654 | CID_654 | |
| 0.019 | 0.127 | 0.084 | Bromodomain-containing protein 3 inhibitor | 0.084 0.008 CID_23017 | CID_23017 | |
| 0.046 | 0.157 | 0.261 | Keratolytic | 0.261 0.005 CID_654 | CID_654 | |
| 0.042 | 0.154 | 0.08 | Potassium channel (Tandem pore domain) blocker | 0.08 0.035 CID_23017 | CID_23017 | |
| 0.017 | 0.129 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 CID_654 | CID_654 | |
| 0.037 | 0.15 | 0.077 | Corticotropin releasing factor 2 receptor antagonist | 0.077 0.019 CID_654 0.062 0.043 CID_23017 | CID_654 | |
| 0.027 | 0.141 | 0.039 | CF transmembrane conductance regulator antagonist | 0.039 0.029 CID_23017 | CID_23017 | |
| 0.004 | 0.119 | 0.015 | Carbonic anhydrase VIII inhibitor | 0.015 0.013 CID_654 | CID_654 | |
| 0.004 | 0.119 | 0.015 | Carbonic anhydrase X inhibitor | 0.015 0.013 CID_654 | CID_654 | |
| 0.01 | 0.126 | 0.047 | Potassium channel small-conductance Ca-activated activator | 0.047 0.012 CID_23017 | CID_23017 | |
| 0.046 | 0.163 | 0.225 | Alcohol dehydrogenase inhibitor | 0.225 0.01 CID_654 | CID_654 | |
| 0.015 | 0.133 | 0.08 | Guanylate cyclase inhibitor | 0.08 0.003 CID_654 | CID_654 | |
| 0.011 | 0.13 | 0.067 | Toll-Like receptor 8 agonist | 0.067 0.003 CID_654 | CID_654 | |
| 0.025 | 0.147 | 0.067 | Glutamate (mGluR4) antagonist | 0.041 0.035 CID_654 0.067 0.011 CID_23017 | CID_23017 | |
| 0.122 | 0.245 | 0.386 | 5 Hydroxytryptamine release stimulant | 0.217 0.108 CID_654 0.386 0.049 CID_23017 | CID_23017 | |
| 0.03 | 0.154 | 0.058 | Epithelial sodium channel blocker | 0.058 0.032 CID_23017 | CID_23017 | |
| 0.065 | 0.193 | 0.209 | Cyclooxygenase 3 inhibitor | 0.209 0.016 CID_654 | CID_654 | |
| 0.017 | 0.145 | 0.064 | Adenosine deaminase inhibitor | 0.064 0.017 CID_654 | CID_654 | |
| 0.013 | 0.143 | 0.108 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.108 0.004 CID_654 | CID_654 | |
| 0.033 | 0.166 | 0.183 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.183 0.012 CID_654 | CID_654 | |
| 0.014 | 0.147 | 0.12 | Carbonic anhydrase VB inhibitor | 0.12 0.012 CID_654 | CID_654 | |
| 0.033 | 0.167 | 0.202 | Potassium channel (Ca-activated) blocker | 0.202 0.005 CID_654 | CID_654 | |
| 0.04 | 0.176 | 0.132 | Glycine receptor antagonist | 0.132 0.012 CID_654 0.095 0.037 CID_23017 | CID_654 | |
| 0.006 | 0.142 | 0.131 | Squalene synthetase inhibitor | 0.131 0.004 CID_654 | CID_654 | |
| 0.004 | 0.141 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 CID_654 | CID_654 | |
| 0.032 | 0.171 | 0.088 | Potassium channel intermediate-conductance Ca-activated blocker | 0.088 0.013 CID_654 | CID_654 | |
| 0.02 | 0.159 | 0.12 | Alcohol oxidase inhibitor | 0.12 0.014 CID_654 0.051 0.044 CID_23017 | CID_654 | |
| 0.075 | 0.215 | 0.2 | Transcription factor STAT6 inhibitor | 0.2 0.007 CID_654 | CID_654 | |
| 0.003 | 0.144 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.009 CID_23017 | CID_23017 | |
| 0.117 | 0.259 | 0.354 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.354 0.012 CID_654 | CID_654 | |
| 0.057 | 0.2 | 0.114 | Vanilloid agonist | 0.114 0.022 CID_654 | CID_654 | |
| 0.025 | 0.17 | 0.067 | Potassium channel (ATP-sensitive) activator | 0.067 0.011 CID_23017 | CID_23017 | |
| 0.011 | 0.156 | 0.119 | Ribonucleotide reductase inhibitor | 0.119 0.017 CID_654 | CID_654 | |
| 0.026 | 0.174 | 0.07 | Potassium channel (Inward rectifier) activator | 0.07 0.011 CID_23017 | CID_23017 | |
| 0.001 | 0.152 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 CID_23017 | CID_23017 | |
| 0.016 | 0.167 | 0.067 | Membrane dipeptidase inhibitor | 0.067 0.008 CID_654 | CID_654 | |
| 0.011 | 0.163 | 0.111 | Ribonucleoside-diphosphate reductase inhibitor | 0.111 0.017 CID_654 | CID_654 | |
| 0.052 | 0.203 | 0.117 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.033 CID_654 0.089 0.074 CID_23017 | CID_654 | |
| 0.046 | 0.202 | 0.28 | Ferrochelatase inhibitor | 0.133 0.046 CID_654 0.28 0.009 CID_23017 | CID_23017 | |
| 0.111 | 0.268 | 0.198 | Heat shock protein 70 antagonist | 0.198 0.007 CID_654 | CID_654 | |
| 0.015 | 0.174 | 0.091 | Thymidylate synthase inhibitor | 0.091 0.005 CID_654 | CID_654 | |
| 0.043 | 0.202 | 0.178 | Creatine kinase inhibitor | 0.178 0.015 CID_654 0.107 0.052 CID_23017 | CID_654 | |
| 0.023 | 0.183 | 0.105 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.105 0.015 CID_654 | CID_654 | |
| 0.026 | 0.188 | 0.11 | Nicotinic alpha4beta2 receptor antagonist | 0.11 0.023 CID_23017 | CID_23017 | |
| 0.007 | 0.17 | 0.049 | Retinoid X receptor agonist | 0.049 0.018 CID_654 | CID_654 | |
| 0.038 | 0.201 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 CID_654 | CID_654 | |
| 0.052 | 0.216 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.1 0.035 CID_654 | CID_654 | |
| 0.052 | 0.216 | 0.213 | Mucolytic | 0.213 0.011 CID_654 | CID_654 | |
| 0.081 | 0.246 | 0.185 | GABA C receptor rho-2 antagonist | 0.156 0.065 CID_654 0.185 0.038 CID_23017 | CID_23017 | |
| 0.008 | 0.175 | 0.026 | Urotensin II agonist | 0.026 0.019 CID_654 | CID_654 | |
| 0.029 | 0.197 | 0.125 | Aminopeptidase I inhibitor | 0.125 0.018 CID_654 | CID_654 | |
| 0.049 | 0.217 | 0.203 | GABA C receptor rho-1 antagonist | 0.203 0.008 CID_654 0.117 0.042 CID_23017 | CID_654 | |
| 0.023 | 0.191 | 0.093 | Catalase inhibitor | 0.093 0.041 CID_654 | CID_654 | |
| 0.048 | 0.219 | 0.14 | Polo-like kinase-1 inhibitor | 0.14 0.02 CID_654 | CID_654 | |
| 0.021 | 0.199 | 0.06 | Aconitate hydratase inhibitor | 0.06 0.026 CID_654 | CID_654 | |
| 0.02 | 0.199 | 0.162 | Carbonic anhydrase V inhibitor | 0.162 0.012 CID_654 | CID_654 | |
| 0.06 | 0.24 | 0.865 | Mcl-1 antagonist | 0.865 0.003 CID_23017 | CID_23017 | |
| 0.024 | 0.205 | 0.087 | Sphingosine kinase 2 inhibitor | 0.087 0.012 CID_654 | CID_654 | |
| 0.012 | 0.197 | 0.042 | Toll-Like receptor 2 agonist | 0.042 0.028 CID_654 | CID_654 | |
| 0.016 | 0.204 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | 0.042 0.033 CID_23017 | CID_23017 | |
| 0.041 | 0.231 | 0.157 | Cystathionine beta-synthase inhibitor | 0.157 0.038 CID_23017 | CID_23017 | |
| 0.024 | 0.214 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.091 0.04 CID_654 | CID_654 | |
| 0.018 | 0.21 | 0.084 | Glutamate (mGluR group III) agonist | 0.084 0.012 CID_654 | CID_654 | |
| 0.048 | 0.24 | 0.268 | Adenylate cyclase inhibitor | 0.268 0.017 CID_654 | CID_654 | |
| 0.016 | 0.212 | 0.102 | NMDA receptor glycine site agonist | 0.057 0.049 CID_654 0.102 0.016 CID_23017 | CID_23017 | |
| 0.032 | 0.229 | 0.153 | Ornithine decarboxylase inhibitor | 0.153 0.01 CID_654 | CID_654 | |
| 0.014 | 0.215 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.017 CID_654 | CID_654 | |
| 0.115 | 0.316 | 0.646 | Immunomodulator | 0.646 0.008 CID_654 | CID_654 | |
| 0.076 | 0.278 | 0.363 | Antiamyloidogenic | 0.363 0.036 CID_654 | CID_654 | |
| 0.042 | 0.246 | 0.084 | Vanilloid 4 agonist | 0.084 0.033 CID_23017 | CID_23017 | |
| 0.033 | 0.238 | 0.164 | Aminopeptidase B inhibitor | 0.164 0.032 CID_654 | CID_654 | |
| 0.081 | 0.286 | 0.132 | Pregnane X receptor agonist | 0.132 0.094 CID_23017 | CID_23017 | |
| 0.042 | 0.249 | 0.275 | Alkylator | 0.275 0.014 CID_654 | CID_654 | |
| 0.019 | 0.226 | 0.073 | Farnesyltransferase inhibitor | 0.073 0.014 CID_654 | CID_654 | |
| 0.024 | 0.233 | 0.09 | Phospholipase D inhibitor | 0.09 0.022 CID_654 0.081 0.033 CID_23017 | CID_654 | |
| 0.033 | 0.244 | 0.24 | Expectorant | 0.24 0.014 CID_654 | CID_654 | |
| 0.02 | 0.231 | 0.058 | GABA B receptor antagonist | 0.058 0.014 CID_654 | CID_654 | |
| 0.015 | 0.226 | 0.075 | Acetylcholine M5 receptor agonist | 0.075 0.038 CID_23017 | CID_23017 | |
| 0.023 | 0.235 | 0.079 | Acetylcholine nicotinic antagonist | 0.079 0.055 CID_23017 | CID_23017 | |
| 0.095 | 0.313 | 0.235 | Superoxide dismutase inhibitor | 0.18 0.141 CID_654 0.235 0.085 CID_23017 | CID_23017 | |
| 0.057 | 0.278 | 0.274 | Protein kinase stimulant | 0.274 0.021 CID_654 | CID_654 | |
| 0.025 | 0.247 | 0.069 | Dihydroorotate oxidase inhibitor | 0.069 0.018 CID_23017 | CID_23017 | |
| 0.007 | 0.228 | 0.02 | Geranylgeranyltransferase I inhibitor | 0.02 0.016 CID_654 | CID_654 | |
| 0.011 | 0.233 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 CID_654 | CID_654 | |
| 0.048 | 0.272 | 0.137 | Microtubule formation inhibitor | 0.137 0.045 CID_654 | CID_654 | |
| 0.127 | 0.352 | 0.193 | 5 Hydroxytryptamine 3E antagonist | 0.186 0.089 CID_654 0.193 0.076 CID_23017 | CID_23017 | |
| 0.046 | 0.271 | 0.449 | Psychostimulant | 0.449 0.016 CID_654 | CID_654 | |
| 0.022 | 0.254 | 0.055 | Heparanase inhibitor | 0.055 0.033 CID_654 | CID_654 | |
| 0.017 | 0.25 | 0.038 | Potassium channel Kv1.1 blocker | 0.038 0.027 CID_23017 | CID_23017 | |
| 0.08 | 0.313 | 0.191 | Neurotrophic factor enhancer | 0.191 0.086 CID_654 | CID_654 | |
| 0.05 | 0.285 | 0.345 | Amyloid beta aggregation inhibitor | 0.345 0.036 CID_654 | CID_654 | |
| 0.133 | 0.37 | 0.27 | Ca(v)3.3 blocker | 0.27 0.073 CID_23017 | CID_23017 | |
| 0.035 | 0.273 | 0.207 | GABA C receptor agonist | 0.132 0.042 CID_654 0.207 0.019 CID_23017 | CID_23017 | |
| 0.015 | 0.258 | 0.069 | AICAR transformylase inhibitor | 0.069 0.01 CID_654 | CID_654 | |
| 0.117 | 0.36 | 0.375 | Antibacterial | 0.375 0.089 CID_654 0.305 0.131 CID_23017 | CID_654 | |
| 0.027 | 0.271 | 0.117 | Interferon agonist | 0.117 0.018 CID_654 | CID_654 | |
| 0.007 | 0.251 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 CID_23017 | CID_23017 | |
| 0.05 | 0.293 | 0.081 | Estrogen-related receptor beta agonist | 0.081 0.063 CID_654 | CID_654 | |
| 0.023 | 0.267 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.061 0.025 CID_23017 | CID_23017 | |
| 0.004 | 0.249 | 0.029 | CXC chemokine 2 receptor antagonist | 0.029 0.015 CID_23017 | CID_23017 | |
| 0.008 | 0.254 | 0.116 | Inosine monophosphate dehydrogenase inhibitor | 0.116 0.004 CID_654 | CID_654 | |
| 0.064 | 0.31 | 0.249 | Aldehyde oxidase inhibitor | 0.249 0.083 CID_654 0.207 0.101 CID_23017 | CID_654 | |
| 0.011 | 0.258 | 0.046 | RNA-directed RNA polymerase inhibitor | 0.046 0.014 CID_654 | CID_654 | |
| 0.005 | 0.255 | 0.04 | Carbonic anhydrase IV inhibitor | 0.04 0.032 CID_654 | CID_654 | |
| 0.018 | 0.268 | 0.062 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.056 CID_654 | CID_654 | |
| 0.045 | 0.295 | 0.136 | Transcription factor NF kappa B stimulant | 0.136 0.019 CID_654 | CID_654 | |
| 0.009 | 0.26 | 0.039 | Dopamine D5 agonist | 0.039 0.03 CID_23017 | CID_23017 | |
| 0.004 | 0.255 | 0.025 | NMDA receptor glycine site antagonist | 0.025 0.016 CID_23017 | CID_23017 | |
| 0.019 | 0.273 | 0.113 | Glutamate decarboxylase inhibitor | 0.113 0.023 CID_654 | CID_654 | |
| 0.015 | 0.273 | 0.076 | Neuronal nicotinic receptor antagonist | 0.076 0.04 CID_23017 | CID_23017 | |
| 0.008 | 0.266 | 0.035 | Nicotinic acid receptor agonist | 0.035 0.027 CID_654 | CID_654 | |
| 0.07 | 0.33 | 0.128 | MAP kinase 3 inhibitor | 0.128 0.113 CID_23017 | CID_23017 | |
| 0.018 | 0.278 | 0.087 | Carbonic anhydrase VA inhibitor | 0.087 0.032 CID_654 | CID_654 | |
| 0.003 | 0.265 | 0.059 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.059 0.004 CID_654 | CID_654 | |
| 0.04 | 0.303 | 0.215 | Beta amyloid protein antagonist | 0.215 0.013 CID_654 | CID_654 | |
| 0.014 | 0.278 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.026 CID_654 | CID_654 | |
| 0.021 | 0.286 | 0.087 | NMDA receptor agonist | 0.087 0.025 CID_23017 | CID_23017 | |
| 0.006 | 0.277 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.027 CID_23017 | CID_23017 | |
| 0.049 | 0.322 | 0.222 | Peroxidase inhibitor | 0.131 0.09 CID_654 0.222 0.053 CID_23017 | CID_23017 | |
| 0.125 | 0.4 | 0.28 | 5 Hydroxytryptamine uptake stimulant | 0.2 0.151 CID_654 0.28 0.057 CID_23017 | CID_23017 | |
| 0.009 | 0.285 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.027 CID_23017 | CID_23017 | |
| 0.017 | 0.294 | 0.06 | Cytokine production stimulant | 0.06 0.013 CID_654 | CID_654 | |
| 0.017 | 0.295 | 0.304 | DNA gyrase inhibitor | 0.304 0.004 CID_23017 | CID_23017 | |
| 0.035 | 0.315 | 0.101 | MAP kinase kinase 1 inhibitor | 0.101 0.055 CID_23017 | CID_23017 | |
| 0.021 | 0.301 | 0.083 | Calcium antagonist | 0.083 0.061 CID_654 | CID_654 | |
| 0.002 | 0.283 | 0.042 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.042 0.004 CID_654 | CID_654 | |
| 0.009 | 0.292 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.02 CID_23017 | CID_23017 | |
| 0.006 | 0.292 | 0.028 | Nicotinic acid receptor 2 antagonist | 0.028 0.016 CID_23017 | CID_23017 | |
| 0.034 | 0.32 | 0.14 | Phosphodiesterase I inhibitor | 0.14 0.02 CID_654 | CID_654 | |
| 0.068 | 0.356 | 0.133 | Interferon gamma antagonist | 0.133 0.104 CID_23017 | CID_23017 | |
| 0.087 | 0.375 | 0.232 | Catenin beta inhibitor | 0.232 0.015 CID_654 | CID_654 | |
| 0.004 | 0.297 | 0.044 | HCV NS5B polymerase inhibitor | 0.044 0.012 CID_654 | CID_654 | |
| 0.01 | 0.302 | 0.046 | Mannosidase inhibitor | 0.046 0.031 CID_654 | CID_654 | |
| 0.054 | 0.348 | 0.367 | Interleukin agonist | 0.367 0.025 CID_654 | CID_654 | |
| 0.027 | 0.322 | 0.143 | Potassium channel large-conductance Ca-activated activator | 0.143 0.012 CID_654 | CID_654 | |
| 0.034 | 0.329 | 0.085 | GABA B receptor agonist | 0.085 0.033 CID_654 0.077 0.048 CID_23017 | CID_654 | |
| 0.043 | 0.342 | 0.115 | Phosphodiesterase 6D inhibitor | 0.115 0.03 CID_654 | CID_654 | |
| 0.061 | 0.362 | 0.176 | Melanin inhibitor | 0.176 0.054 CID_654 | CID_654 | |
| 0.136 | 0.438 | 0.355 | 5 Hydroxytryptamine release inhibitor | 0.294 0.172 CID_654 0.355 0.111 CID_23017 | CID_23017 | |
| 0.161 | 0.472 | 0.432 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.303 0.209 CID_654 0.432 0.074 CID_23017 | CID_23017 | |
| 0.043 | 0.356 | 0.2 | Cell wall synthesis inhibitor | 0.2 0.03 CID_654 | CID_654 | |
| 0.039 | 0.352 | 0.301 | Toll-Like receptor antagonist | 0.301 0.007 CID_654 | CID_654 | |
| 0.008 | 0.322 | 0.043 | GABA uptake inhibitor | 0.043 0.022 CID_654 | CID_654 | |
| 0.037 | 0.353 | 0.073 | MDM2 inhibitor | 0.073 0.032 CID_23017 | CID_23017 | |
| 0.004 | 0.321 | 0.103 | Purinergic P2T antagonist | 0.103 0.005 CID_654 | CID_654 | |
| 0.016 | 0.336 | 0.042 | Kainate receptor agonist | 0.042 0.028 CID_23017 | CID_23017 | |
| 0.019 | 0.34 | 0.065 | 5 Hydroxytryptamine 3 agonist | 0.065 0.041 CID_23017 | CID_23017 | |
| 0.005 | 0.328 | 0.098 | Purinergic P2Y12 antagonist | 0.098 0.004 CID_654 | CID_654 | |
| 0.011 | 0.335 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.027 CID_654 | CID_654 | |
| 0.013 | 0.341 | 0.117 | HIV-1 reverse transcriptase inhibitor | 0.117 0.023 CID_654 0.116 0.024 CID_23017 | CID_654 | |
| 0.029 | 0.36 | 0.112 | HIV-1 integrase (Overall Integration) inhibitor | 0.112 0.045 CID_23017 | CID_23017 | |
| 0.078 | 0.409 | 0.469 | Antithrombotic | 0.469 0.034 CID_654 | CID_654 | |
| 0.033 | 0.374 | 0.124 | Electrolyte absorption antagonist | 0.124 0.033 CID_23017 | CID_23017 | |
| 0.01 | 0.351 | 0.071 | Benzodiazepine agonist | 0.071 0.049 CID_23017 | CID_23017 | |
| 0.01 | 0.359 | 0.034 | Integrin alpha2 antagonist | 0.034 0.031 CID_23017 | CID_23017 | |
| 0.027 | 0.38 | 0.094 | AMP-activated protein kinase stimulant | 0.094 0.078 CID_23017 | CID_23017 | |
| 0.003 | 0.358 | 0.023 | Neutral endopeptidase inhibitor | 0.023 0.014 CID_654 | CID_654 | |
| 0.029 | 0.39 | 0.207 | Cytidine deaminase inhibitor | 0.207 0.044 CID_654 | CID_654 | |
| 0.009 | 0.372 | 0.039 | Sphingosine kinase 1 inhibitor | 0.039 0.033 CID_654 | CID_654 | |
| 0.014 | 0.377 | 0.1 | CDC25A inhibitor | 0.1 0.028 CID_654 | CID_654 | |
| 0.038 | 0.411 | 0.434 | Hypolipemic | 0.434 0.02 CID_654 | CID_654 | |
| 0.052 | 0.427 | 0.178 | DNA repair enzyme inhibitor | 0.178 0.014 CID_654 | CID_654 | |
| 0.008 | 0.385 | 0.091 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.091 0.008 CID_23017 | CID_23017 | |
| 0.035 | 0.42 | 0.109 | Interleukin 8 antagonist | 0.109 0.079 CID_23017 | CID_23017 | |
| 0.006 | 0.392 | 0.056 | NMDA 2C receptor antagonist | 0.056 0.05 CID_23017 | CID_23017 | |
| 0.017 | 0.404 | 0.084 | Potassium channel (Voltage-sensitive) activator | 0.084 0.08 CID_23017 | CID_23017 | |
| 0.009 | 0.396 | 0.104 | Poly(ADP-ribose) polymerase inhibitor | 0.104 0.008 CID_23017 | CID_23017 | |
| 0.052 | 0.445 | 0.228 | Cyclic AMP phosphodiesterase inhibitor | 0.228 0.076 CID_654 | CID_654 | |
| 0.05 | 0.45 | 0.213 | DNA damaging | 0.213 0.105 CID_654 | CID_654 | |
| 0.05 | 0.455 | 0.196 | Calpain 2 inhibitor | 0.196 0.191 CID_23017 | CID_23017 | |
| 0.01 | 0.417 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.045 CID_654 | CID_654 | |
| 0.041 | 0.451 | 0.287 | DNA methylase inhibitor | 0.287 0.032 CID_654 | CID_654 | |
| 0.073 | 0.486 | 0.341 | Vasodilator, coronary | 0.341 0.06 CID_654 | CID_654 | |
| 0.024 | 0.437 | 0.076 | Phosphodiesterase VI inhibitor | 0.076 0.048 CID_654 | CID_654 | |
| 0.022 | 0.436 | 0.086 | Prolactin inhibitor | 0.086 0.072 CID_23017 | CID_23017 | |
| 0.017 | 0.434 | 0.047 | CXC chemokine 1 receptor antagonist | 0.047 0.044 CID_23017 | CID_23017 | |
| 0.049 | 0.469 | 0.282 | DNA directed DNA polymerase inhibitor | 0.282 0.172 CID_654 | CID_654 | |
| 0.022 | 0.453 | 0.129 | Neurotrophic factor | 0.129 0.081 CID_654 | CID_654 | |
| 0.007 | 0.442 | 0.085 | HIV-1 integrase (3'-Processing) inhibitor | 0.085 0.032 CID_654 | CID_654 | |
| 0.02 | 0.471 | 0.166 | Aryl hydrocarbon receptor agonist | 0.166 0.123 CID_23017 | CID_23017 | |
| 0.047 | 0.507 | 0.234 | Transcription factor NF kappa B inhibitor | 0.234 0.139 CID_654 | CID_654 | |
| 0.046 | 0.507 | 0.15 | CF transmembrane conductance regulator agonist | 0.15 0.076 CID_23017 | CID_23017 | |
| 0.013 | 0.486 | 0.353 | Nav1.8 sodium channel blocker | 0.353 0.004 CID_23017 | CID_23017 | |
| 0.018 | 0.5 | 0.135 | 5 Hydroxytryptamine 3A agonist | 0.135 0.044 CID_23017 | CID_23017 | |
| 0.025 | 0.513 | 0.083 | Bromodomain-containing protein 2 inhibitor | 0.083 0.07 CID_23017 | CID_23017 | |
| 0.039 | 0.53 | 0.155 | 3C-like protease (Human coronavirus) inhibitor | 0.155 0.092 CID_23017 | CID_23017 | |
| 0.025 | 0.518 | 0.157 | Heat shock protein 90 antagonist | 0.157 0.068 CID_23017 | CID_23017 | |
| 0.008 | 0.507 | 0.072 | CDC7 inhibitor | 0.072 0.042 CID_23017 | CID_23017 | |
| 0.014 | 0.53 | 0.183 | Sodium channel blocker | 0.183 0.039 CID_23017 | CID_23017 | |
| 0.026 | 0.572 | 0.419 | Vasodilator | 0.419 0.02 CID_654 | CID_654 | |
| 0.044 | 0.595 | 0.317 | Histamine release inhibitor | 0.317 0.115 CID_654 | CID_654 | |
| 0.006 | 0.558 | 0.179 | c-Src kinase inhibitor | 0.179 0.042 CID_654 | CID_654 | |
| 0.02 | 0.572 | 0.271 | Angiogenesis stimulant | 0.271 0.061 CID_654 | CID_654 | |
| 0.009 | 0.57 | 0.157 | Sodium channel (voltage-gated) blocker | 0.157 0.05 CID_23017 | CID_23017 | |
| 0.005 | 0.566 | 0.082 | HIV-1 integrase (Strand Transfer) inhibitor | 0.082 0.03 CID_654 | CID_654 | |
| 0.058 | 0.62 | 0.251 | Apoptosis antagonist | 0.251 0.127 CID_654 | CID_654 | |
| 0.012 | 0.585 | 0.145 | Cyclooxygenase 1 inhibitor | 0.145 0.059 CID_23017 | CID_23017 | |
| 0.031 | 0.607 | 0.152 | Hematopoietic | 0.152 0.015 CID_654 | CID_654 | |
| 0.015 | 0.611 | 0.151 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.151 0.077 CID_23017 | CID_23017 | |
| 0.021 | 0.629 | 0.119 | Hemostatic | 0.119 0.117 CID_654 | CID_654 | |
| 0.042 | 0.653 | 0.322 | Vasodilator, peripheral | 0.322 0.086 CID_654 | CID_654 | |
| 0.016 | 0.631 | 0.384 | Antimitotic | 0.384 0.025 CID_654 | CID_654 | |
| 0.015 | 0.64 | 0.215 | Spasmolytic | 0.215 0.108 CID_654 | CID_654 | |
| 0.018 | 0.645 | 0.055 | Cathepsin E inhibitor | 0.055 0.048 CID_654 | CID_654 | |
| 0.008 | 0.636 | 0.129 | Tubulin antagonist | 0.129 0.072 CID_654 | CID_654 | |
| 0.007 | 0.639 | 0.071 | ZAP-70 protein tyrosine kinase inhibitor | 0.071 0.047 CID_654 | CID_654 | |
| 0.012 | 0.661 | 0.308 | Chelator | 0.308 0.01 CID_654 | CID_654 | |
| 0.012 | 0.675 | 0.26 | Platelet antagonist | 0.26 0.068 CID_654 | CID_654 | |
| 0.014 | 0.69 | 0.197 | Platelet aggregation inhibitor | 0.197 0.083 CID_654 | CID_654 | |
| 0.019 | 0.722 | 0.211 | Platelet adhesion inhibitor | 0.211 0.066 CID_654 | CID_654 | |
| 0.007 | 0.711 | 0.068 | Aminopeptidase microsomal inhibitor | 0.068 0.033 CID_654 | CID_654 | |
| 0.005 | 0.739 | 0.068 | Endothelin-converting enzyme inhibitor | 0.068 0.021 CID_654 | CID_654 | |
| 0.004 | 0.766 | 0.05 | Aminopeptidase N inhibitor | 0.05 0.031 CID_654 | CID_654 | |
| 0.009 | 0.784 | 0.123 | Breast cancer-resistant protein inhibitor | 0.123 0.038 CID_654 | CID_654 | |
| 0.007 | 0.795 | 0.152 | Death-associated protein kinase 3 inhibitor | 0.152 0.118 CID_23017 | CID_23017 | |
| 0.011 | 0.858 | 0.063 | Polo-like kinase-2 inhibitor | 0.063 0.061 CID_654 | CID_654 | |
| 0.004 | 0.852 | 0.103 | HIV-1 integrase inhibitor | 0.103 0.023 CID_654 | CID_654 | |
| 0.005 | 0.873 | 0.134 | Lipid peroxidase inhibitor | 0.134 0.08 CID_654 | CID_654 | |
| 0.003 | 0.947 | 0.108 | Protein-tyrosine phosphatase 1B inhibitor | 0.108 0.071 CID_654 | CID_654 | |
| 0.005 | 0.967 | 0.268 | Tumour necrosis factor alpha release inhibitor | 0.268 0.066 CID_654 | CID_654 | |
| 0.002 | 0.968 | 0.025 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.025 0.005 CID_23017 | CID_23017 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |